Emera (TSE:EMA – Get Free Report) was upgraded by investment analysts at TD Securities to a “strong-buy” rating in a report issued on Friday, Marketbeat reports. The firm currently has a C$69.00 price objective on the stock. TD Securities’ target price would suggest a potential upside of 12.03% from the stock’s current price.
A number of other analysts have also commented on EMA. Desjardins set a C$62.00 target price on shares of Emera and gave the stock a “hold” rating in a report on Tuesday, May 6th. BMO Capital Markets lifted their price target on shares of Emera from C$60.00 to C$65.00 and gave the stock an “outperform” rating in a research report on Friday, May 9th. UBS Group lifted their price target on shares of Emera from C$54.00 to C$59.00 in a research report on Friday, March 21st. CIBC upped their target price on shares of Emera from C$63.00 to C$64.00 and gave the stock an “outperform” rating in a research note on Thursday, April 24th. Finally, Raymond James Financial cut their price target on shares of Emera from C$64.00 to C$59.00 and set an “outperform” rating on the stock in a research report on Thursday, April 17th. Three analysts have rated the stock with a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of C$60.58.
Emera Stock Performance
Emera Company Profile
Emera Incorporated, through its subsidiaries, engages in the generation, transmission, and distribution of electricity to various customers. The company operates through Florida Electric Utility, Canadian Electric Utilities, Other Electric Utilities, Gas Utilities and Infrastructure, and Other segments.
Featured Articles
- Five stocks we like better than Emera
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making?
- How to Plot Fibonacci Price Inflection Levels
- Value Alert: 3 High-Yield Stocks Trading at 52-Week Lows
- Using the MarketBeat Dividend Yield Calculator
- Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?
Receive News & Ratings for Emera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emera and related companies with MarketBeat.com's FREE daily email newsletter.